Skip Navigation
Menu
Ideas and Opinions |15 September 1996

Prophylaxis for Occupational Exposure to HIV

Julie Louise Gerberding, MD, MPH

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
Copyright ©2004 by the American College of Physicians
  • From San Francisco General Hospital, San Francisco, California. For the current author address, see end of text. Note: Dr. Gerberding was a corporate consultant for Kimberly Clarke and 3M Corporation and was supported by Glaxo-Wellcome, Pfizer, and Bayer while preparing this paper. Requests for Reprints: Julie Louise Gerberding, MD, MPH, Epidemiology and Prevention Interventions Center, Medical Service 5H22, San Francisco General Hospital, 1001 Potrero Avenue, San Francisco, CA 94110.
×
FULL TEXT
Health care providers who are parenterally exposed to human immunodeficiency virus (HIV) are at risk for infection. The average risk attributed to needle punctures and similar percutaneous injuries involving HIV is approximately 0.32% (95% CI, 0.18% to 0.46%), or 21 infections after 6498 exposures [1-3]. This risk estimate, which is based on data taken from 25 prospective studies of occupational exposure, does not account for factors that may change the probability of transmission during a specific exposure. The virus inoculum (the volume of material involved in an exposure and the titer of infectious virus in that material) is one important determinant of risk. New data suggest that antiretroviral treatment after exposure may also be an important factor affecting the outcome of occupational exposure to HIV.
In a case–control study, the Centers for Disease Control and Prevention (CDC) found that five factors were independently associated with the risk for HIV infection after percutaneous injury (Table 1) [4]. Three of these factors (deep injuries, visible blood on the device before injury, and devices that were used in an artery or vein before injury are probably markers for exposure to a greater volume of infected blood. Exposure to blood from a source patient with preterminal acquired immunodeficiency syndrome [AIDS] was also associated with an increased risk for infection (patients were considered preterminal if they died within 2 months of the exposure). High virus titers, which are typically present in advanced HIV disease, and possibly phenotypic or genotypic differences among...
FULL TEXT
PDF
Not Available
Citations
Citation

Gerberding JL. Prophylaxis for Occupational Exposure to HIV. Ann Intern Med. 1996;125:497–501. doi: https://doi.org/10.7326/0003-4819-125-6-199609150-00011

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 1996;125(6):497-501.

DOI: 10.7326/0003-4819-125-6-199609150-00011

87 Citations

Related Articles
Surveillance of HIV Infection and Zidovudine Use among Health Care Workers after Occupational Exposure to HIV-Infected Blood
Annals of Internal Medicine; 118 (12): 913-919
Is Antiretroviral Treatment after Percutaneous HIV Exposure Justified?
Annals of Internal Medicine; 118 (12): 979-980
Didanosine Resistance in HIV-infected Patients Switched from Zidovudine to Didanosine Monotherapy
Annals of Internal Medicine; 121 (4): 263-268
Combination Therapy With Telaprevir for Chronic Hepatitis C Virus Genotype 1 Infection in Patients With HIV: A Randomized Trial
Annals of Internal Medicine; 159 (2): 86-96
View MoreView Less

Journal Club
Isoniazid prevented active tuberculosis in patients with HIV treated with antiretroviral therapy
Annals of Internal Medicine; 161 (6): JC12
Pericoital application of tenofovir gel reduced risk for herpes simplex virus type 2 in HIV-negative women
Annals of Internal Medicine; 163 (12): JC6
Prophylactic tenofovir reduced HIV infection in injectable drug users
Annals of Internal Medicine; 159 (6): JC8
A clinical decision-support system with interactive alerts improved CD4 cell count in HIV
Annals of Internal Medicine; 158 (8): JC11
View MoreView Less

Related Point of Care
Management of Newly Diagnosed HIV Infection
Annals of Internal Medicine; 167 (1): ITC1-ITC16
Management of Newly Diagnosed HIV Infection
Annals of Internal Medicine; 155 (7): ITC4-1
View MoreView Less

Related Topics
HIV
Infectious Disease

HIV, Infectious Disease.

PubMed Articles
Adverse health effects of abuse-deterrent opioids: Evidence from the reformulation of OxyContin.
Health Econ 2019.
Detection and quantification of human immunodeficiency virus and hepatitis C virus in cadaveric tissue donors using different molecular tests.
J Clin Virol 2019;
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×